Results 141 to 150 of about 34,165 (229)

Quieting the carrier: Matching delivery to immunology in anti-inflammatory mRNA therapy. [PDF]

Mol Ther Nucleic Acids
Candiani G.
europepmc   +1 more source

Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39⁺CD8⁺ T cells highlights immunotherapy-resistant features in NSCLC. [PDF]

J Immunother Cancer
Wu J, Zhai J, Lv L, Zhang Y, Shen Y, Qu Q, Chen C.   +6 more
europepmc   +1 more source

Ectonucleotidases CD39 and CD73 expression levels are independent and inverse predictors of survival in muscle-invasive bladder cancer. [PDF]

J Pathol Clin Res
Ledderose S, Schwenke J, Eismann L, Rodler S, Rudelius M, Ledderose C.   +5 more
europepmc   +1 more source

Nanomaterials Reshaping Tumor Metabolism: A New Frontier to Overcome T Cell Exhaustion. [PDF]

Int J Nanomedicine
Zhu X, He L, Li J, Guo S, Liu X, Cao Y, Song S.   +6 more
europepmc   +1 more source

Enhanced CD33 CAR-NK cells secreting anti-CD73scFv overcome adenosine-mediated immunosuppression and improve anti-AML efficacy. [PDF]

J Immunother Cancer
Wang L, Gong S, Wang J, Bao Y, Mei N, Lu X, Chen W, Xi L, Zhang H, Chen X, Ning P, Fan X, Wang H.   +12 more
europepmc   +1 more source

Cancer associated fibroblast-T cell crosstalk promotes purinergic synthesis in non-small cell lung cancer (NSCLC). [PDF]

Oncoimmunology
Koppensteiner L, Lochenie C, O'Connor RA, Mathieson L, Neilson L, Akram AR.   +5 more
europepmc   +1 more source

CD73 and PD-L1 expression in WHO grade 1 and grade 2 meningiomas: an exploratory analysis of purinergic and immune-related profiles. [PDF]

J Neurooncol
de Souza JVG, Pretto KP, da Silva LVG, Oenning BAM, Pin C, Menegassi J, Franscescon F, Chimelo MB, da Cunha MLV, de Resende E Silva DT.   +9 more
europepmc   +1 more source

CD26 + CD39 - CD73 + CD4 + T lymphocytes decrease after HIV-1 infection but show an intrinsic association with low viral replication and high CD4 + T-cell count. [PDF]

Chin Med J (Engl)
Zhang X, Jin J, Xu Q, Zhu A, Ding N, Liu Z, Yuan L, Lu X, Li Z, Wang R, Ma Z, Xia W, Zhang T, Su B.   +13 more
europepmc   +1 more source

Augmenting CAR T cell functionality and metabolism through CD39 downtuning. [PDF]

Mol Ther Oncol
Harrer DC, Baldwin J, Barden M, Pan H, Gergely B, Szöőr Á, Vereb G, Herr W, Abken H.   +8 more
europepmc   +1 more source

Gap junctions and hemichannels in cancer: A "Wired versus Broadcast" framework for tumor microenvironment routing of cGAMP-STING signals and therapy response. [PDF]

Transl Oncol
Akbari-Ardabili S, Aghazadeh S, Shalizar-Jalali A, Hosseinzadeh F.   +3 more
europepmc   +1 more source